Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2022 IKCS: North America
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Email
Tweet this
Print
Bradley McGregor, MD
Director of Clinical Research
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Poster(s):
31: Updated efficacy of lenvatinib + pembrolizumab versus sunitinib in patients with advanced renal cell carcinoma (aRCC) in the CLEAR study
Email Bradley
